Published in Pacing Clin Electrophysiol on November 01, 1994
The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med (1992) 6.05
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clin Pharmacol Ther (2011) 4.42
Clinical use of the total artificial heart. N Engl J Med (1984) 2.94
A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction. N Engl J Med (1983) 2.85
ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol (1996) 2.81
Quantitative volumetric analysis of brain MR: normative database spanning 5 decades of life. AJNR Am J Neuroradiol (1995) 2.80
Preventing adverse drug events in hospitalized patients. Ann Pharmacother (1994) 2.74
Effect of practice variation on resource utilization in infants hospitalized for viral lower respiratory illness. Pediatrics (2001) 2.72
Results of a collaborative quality improvement program on outcomes and costs in a tertiary critical care unit. Crit Care Med (1999) 2.72
The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport. N Engl J Med (1984) 2.71
International comparison of waiting times for selected cardiovascular procedures. J Am Coll Cardiol (1995) 2.71
Measuring severity of illness: comparisons across institutions. Am J Public Health (1983) 2.49
An emergency department-based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense: results of a randomized study (ROMIO). J Am Coll Cardiol (1996) 2.46
Restricted transport in small pores. A model for steric exclusion and hindered particle motion. Biophys J (1974) 2.42
The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis (1988) 2.42
Relation of dispersion of QRS and QT in patients with advanced congestive heart failure to cardiac and sudden death mortality. Am J Cardiol (2000) 2.31
Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet (1968) 2.29
HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Validation study and meta-analysis of published HLA association studies. Circulation (1991) 2.22
Integration of genetic, clinical, and INR data to refine warfarin dosing. Clin Pharmacol Ther (2010) 2.21
Time delays in the diagnosis and treatment of acute myocardial infarction: a tale of eight cities. Report from the Pre-hospital Study Group and the Cincinnati Heart Project. Am Heart J (1990) 2.14
Mechanism of osmotic flow in porous membranes. Biophys J (1974) 2.07
Interhospital differences in severity of illness. Problems for prospective payment based on diagnosis-related groups (DRGs). N Engl J Med (1985) 2.00
Oral flecainide acetate for the treatment of ventricular arrhythmias. N Engl J Med (1981) 1.99
Measuring severity of illness: homogeneous case mix groups. Med Care (1983) 1.99
Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation (2000) 1.92
Standardized full-field electroretinography. Normal values and their variation with age. Arch Ophthalmol (1992) 1.92
Coronary spasm producing coronary thrombosis and myocardial infarction. N Engl J Med (1983) 1.91
A survey to evaluate parental consent as public policy for neonatal screening. Am J Public Health (1982) 1.89
Idiopathic cardiomyopathy, age, and suppressor-cell dysfunction as risk determinants of lymphoma after cardiac transplantation. Lancet (1978) 1.87
Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation (1998) 1.86
Continuity and coordination in primary care: their achievement and utility. Med Care (1976) 1.85
The Severity of Illness Index as a severity adjustment to diagnosis-related groups. Health Care Financ Rev (1984) 1.84
Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy. Ophthalmology (1999) 1.80
A study of the relationship between severity of illness and hospital cost in New Jersey hospitals. Health Serv Res (1992) 1.78
Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study. Circulation (2000) 1.74
Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation (1995) 1.73
Continuity of care: is it cost effective? Am J Manag Care (1999) 1.71
Implementation of a computerized cardiovascular information system in a private hospital setting. Am Heart J (1998) 1.68
Measuring severity of illness to predict patient resource use within DRGs. Inquiry (1983) 1.65
S-cone function in patients with retinitis pigmentosa. Invest Ophthalmol Vis Sci (1993) 1.65
Patient information recall in a rheumatology clinic. Rheumatol Rehabil (1979) 1.62
Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation (2001) 1.61
Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group. Circulation (1991) 1.59
Validity, reliability and implications of an index of inpatient severity of illness. Med Care (1981) 1.59
HLA haplotypes in a family with multiple cases of rheumatoid arthritis. J Rheumatol (1982) 1.59
Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol (1996) 1.55
Information factors affecting problem follow-up in ambulatory care. Med Care (1976) 1.51
Severity assessment in children hospitalized with bronchiolitis using the pediatric component of the Comprehensive Severity Index. Pediatr Crit Care Med (2000) 1.49
An analysis of case mix complexity using information theory and diagnostic related grouping. Med Care (1979) 1.47
Partitioning and diffusion of proteins and linear polymers in polyacrylamide gels. Biophys J (1996) 1.46
Effect of joint motion on experimental calcium pyrophosphate dihydrate crystal induced arthritis. J Rheumatol (1990) 1.46
Changes in spontaneous variability of ventricular ectopic activity as a function of time in patients with chronic arrhythmias. Circulation (1988) 1.45
Patient preferences and the bedside manner. Med Educ (1982) 1.41
Measuring severity: how sick is sick? How well is well? Healthc Financ Manage (1986) 1.41
Genetics informatics trial (GIFT) of warfarin to prevent deep vein thrombosis (DVT): rationale and study design. Pharmacogenomics J (2011) 1.38
Nuclear preparations of SV40-transformed cells contain tumor-specific transplantation antigen activity. Virology (1977) 1.37
Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol (1990) 1.35
Does severity of illness make a difference in prospective payment? Healthc Financ Manage (1983) 1.32
Variations in utilization of health services by children. Pediatrics (1979) 1.32
Hospital case mix groupings and generic algorithms. QRB Qual Rev Bull (1982) 1.30
Severity of illness within DRGs. Homogeneity study. Med Care (1986) 1.30
Thrombolysis and myocardial salvage. Results of clinical trials and the animal paradigm--paradoxic or predictable? Circulation (1993) 1.28
Ambulatory severity index: development of an ambulatory case mix system. J Ambul Care Manage (1988) 1.27
Reduction in QT interval dispersion by successful thrombolytic therapy in acute myocardial infarction. TEAM-2 Study Investigators. Circulation (1994) 1.26
Malignant neoplasms following cardiac transplantation. JAMA (1978) 1.24
Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality. Am J Cardiol (2001) 1.24
Risk factors for congenital hypothyroidism: an investigation of infant's birth weight, ethnicity, and gender in California, 1990-1998. Teratology (2000) 1.23
Treatment of breast cancer: doctor/patient communication and psychosocial implications. Proc R Soc Med (1975) 1.23
Model pores of molecular dimension. The preparation and characterization of track-etched membranes. Biophys J (1972) 1.21
Kinetics and yield of singlet oxygen photosensitized by hypericin in organic and biological media. Photochem Photobiol (1998) 1.21
Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease. J Am Coll Cardiol (2000) 1.20
A randomized trial of intravenous and intracoronary streptokinase in patients with acute myocardial infarction. Circulation (1984) 1.19
Coffee consumption and cause-specific mortality. Association with age at death and compression of mortality. J Clin Epidemiol (1992) 1.17
Measuring severity of illness: a reliability study. Med Care (1983) 1.16
Expression and thermal stability of simian virus 40 tumor-specific transplantation antigen and tumor antigen in wild type- and tsA mutant-transformed cells. J Virol (1977) 1.15
Neutrophil dysfunction in diabetes mellitus. J Lab Clin Med (1975) 1.15
SV40 transformation of mouse brain cells: critical role of gene A in maintenance of the transformed phenotype. J Cell Physiol (1976) 1.14
Generating genetic risk scores from intermediate phenotypes for use in association studies of clinically significant endpoints. Ann Hum Genet (2005) 1.13
HLA A, B and DR typing in idiopathic dilated cardiomyopathy: a search for immune response factors. Am J Cardiol (1984) 1.13
The effect of carbidopa on the pharmacokinetics of intravenously administered levodopa: the mechanism of action in the treatment of parkinsonism. Ann Neurol (1985) 1.13
Vancomycin pharmacokinetics, renal handling, and nonrenal clearances in normal human subjects. Clin Pharmacol Ther (1988) 1.12
Novel cardiac troponin T mutation as a cause of familial dilated cardiomyopathy. Circulation (2001) 1.12
The Computerized Psychiatric Severity Index as a predictor of inpatient length of stay for psychoses. Med Care (1991) 1.11
TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 Study. Circulation (1993) 1.10
Comparing classification methods: measurement of variations in charges, length of stay, and mortality. Med Care (1982) 1.09
A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy. Am J Cardiol (1985) 1.08
Goodness-of-fit tests for discrete data: a review and an application to a health impairment scale. Biometrics (1977) 1.08
Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo. Am J Med (1990) 1.08
Hamstrings vs. patella tendon for anterior cruciate ligament reconstruction: a randomised controlled trial. Knee (2001) 1.08